Indication · GI, Urology & Nephrology
Colorectal cancer and polyps
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
237
Cleared or approved since 2000
PMA and De Novo
19
Higher-risk or first-of-kind devices
Breakthrough devices
1
Authorized through June 30, 2026
Recruiting device trials
66
693 device trials in all
Breakthrough-designated devices
- ColoSense®Geneoscopy, Inc. · 2026
Devices
237 devices. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Cologuard
Exact Sciences Corporation · PMA · System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection · newest 2024 · 8 decisions
59 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- The Vanguard Study: Testing a New Way to Screen for CancerPivotal-lookingRecruiting
National Cancer Institute (NCI)NIH
NCT06995898 · 24,000 participants (planned) · Start Jun 18, 2025 · Primary completion Jan 31, 2029
Device: Device Usage · For: Bladder Carcinoma; Breast Carcinoma; Colorectal Carcinoma and 8 more
Sites: Pleasanton, California; San Diego, California; Cheyenne Wells, Colorado · 49 sites in all
692 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Colonoscope And Accessories, Flexible/Rigid (FDF)71
- Snare, Flexible (FDI)37
- Reagent, Occult Blood (KHE)34
- Forceps, Biopsy, Electric (KGE)24
- Stent, Colonic, Metallic, Expandable (MQR)10
- Gastrointesinal Lesion Software Detection System (QNP)10
- Submucosal Injection Agent (PLL)8
- System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection (PHP)7
- Automated Occult Blood Analyzer (OOX)6
- Lynch Syndrome Test System (PZJ)5
- Colon Computed Tomography System, Computer Aided Detection (NWE)4
- Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay (QNH)3
- Analyzer, Diagnostic, Fiber Optic (Colon) (MOA)2
- Marker, Colon (NBG)2
- Colon Capsule Imaging System (PGD)2
- Endoscopic Morcellator Gastroenterology (PTE)2
- Endoscopic Traction Device (QSW)2
- Sigmoidoscope, Rigid, Electrical (FAN)1
- Sigmoidoscope, Rigid, Non-Electrical (KDM)1
- Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor (NQF)1
- System, Test, Fibrin/Fibrinogen Degradation Products For Monitoring Of Colorectal Cancer (NTY)1
- Control, Fecal Occult Blood (OSL)1
- Spatial Imaging For Display Of Endoscope Position (PGU)1
- Endoscopic Light-Projecting Measuring Device (QTH)1
- System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection (SBB)1
Research
- Device studies on colorectal cancer across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.